Yahoo Web Search

Search results

    • Down 72%. Is Ginkgo Bioworks a Buy on the Dip?

      The Motley Fool via AOL· 1 day ago

      It has been difficult to be a shareholder of Ginkgo Bioworks (NYSE: DNA) over the past year. The stock has collapsed about 72% from its peak last summer. The company's cell ...